======= FLG2 =======
== Gene Information ==
* **Official Symbol**: FLG2
* **Official Name**: filaggrin family member 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=388698|388698]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5D862|Q5D862]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FLG2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FLG2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616284|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|S 100|
|keratohyalin granule|
|structural constituent of epidermis|
|transition metal ion binding|
|establishment of skin barrier|
|regulation of water loss via skin|
|epidermis morphogenesis|
|tertiary granule lumen|
|cornified envelope|
|multicellular organismal water homeostasis|
|water homeostasis|
|multicellular organismal homeostasis|
|skin development|
|epidermis development|
|morphogenesis of an epithelium|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|regulation of body fluid levels|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|tissue morphogenesis|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|regulated exocytosis|
|calcium ion binding|
|leukocyte mediated immunity|
|exocytosis|
|leukocyte activation|
|cell adhesion|
|biological adhesion|
|secretion by cell|
|export from cell|
|cell activation|
|immune effector process|
|chemical homeostasis|
|epithelium development|
|secretion|
|homeostatic process|
|tissue development|
|immune response|
|extracellular region|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-2.17|
|[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-1.91|
|[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-1.78|
|[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|1.77|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14297
* **Expression level (log2 read counts)**: 1.0
{{:chemogenomics:nalm6 dist.png?nolink |}}